Vor Biopharma Inc. is an innovative biopharmaceutical company based in Cambridge, Massachusetts, focused on pioneering hematopoietic stem cell (eHSC) therapies for the treatment of cancer. Leveraging proprietary technology platforms, Vor aims to create targeted and effective therapies that enhance the durable response and overall survival of patients. The company's commitment to advancing cell therapies positions it at the forefront of the rapidly evolving oncology landscape, making it a compelling prospect for institutional investors seeking exposure to next-generation cancer treatments.